Related Experiment Videos
Fever in the neutropenic host
1Infectious Disease Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Infectious Disease Clinics of North America
|December 1, 1996
Abstract:
Fever in the neutropenic patient following myelosuppressive chemotherapy is a medical emergency. Appropriate antimicrobial therapy can dramatically reduce infection-related morbidity and mortality. This article reviews the rationale and methodology of treatment as well as its applicability to other neutropenic states. The utility of adjunct therapy with granulocyte- stimulating compounds is also discussed.